Multiple Regression Analysis of Predictors of Bone Scintigraphy Positivity in Patients with Head and Neck Cancers
- PMID: 29391914
- PMCID: PMC5777959
- DOI: 10.1007/s13139-017-0492-7
Multiple Regression Analysis of Predictors of Bone Scintigraphy Positivity in Patients with Head and Neck Cancers
Abstract
Purpose: The value of bone scintigraphy (BS) in patients with head and neck cancers (HNCs) has been questioned, with conflicting findings regarding positivity yield with some reports recommending BS be omitted from work-up of HNC patients since it rarely yields positive results. This study aims to determine the positivity yield of BS in HNCs and to determine predictors for BS positivity to help tailor appropriate BS utilization.
Methods: BS studies of HNC patients were reviewed, the positivity yield was determined. Clinical predictors for BS positivity including age, sex, site of cancer, staging, histological grading were analyzed using univariable and multivariable logistic regression.
Results: Among the 259 BS studies included, 35 (13.5%), 194 (74.9%), and 30 (11.6%) were positive, negative, and equivocal for bone metastasis, respectively. After exclusion of equivocal cases, 229 were analyzed in the regression models. Independent predictors of BS positivity include site of tumor at the nasopharynx (OR 4.37, 95% C.I. 1.04-18.41, p = 0.044), age less than 45 years (OR 3.01, 95% C.I. 1.24-7.33, p = 0.015), and presence of distant metastasis to other organs (OR 3.84, 95% C.I. 1.19-12.43, p = 0.025).
Conclusions: In contrast to several studies, bone metastasis as detected by BS was found in a relatively high proportion of patients with HNCs. Independent predictors of BS positivity include the age of less than 45 years, tumor site at the nasopharynx, and the presence of extraskeletal distant metastasis. BS could be useful in patients with these characteristics which enhance the pretest probability of bone metastasis.
Keywords: Bone metastasis; Bone scintigraphy; Head and neck cancers; Radionuclide imaging.
Conflict of interest statement
Compliance with Ethical StandardsDaris Theerakulpisut, Nantaporn Wongsurawat, Narudom Supakalin, and Charoonsak Somboonporn, declare that they have no conflict of interest. No funding was received for conduction of this study.All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.The institutional review board of our institute approved this retrospective study, and the requirement to obtain informed consent was waived.
Similar articles
-
When to Perform Preoperative Bone Scintigraphy for Kidney Cancer Staging: Indications for Preoperative Bone Scintigraphy.Urology. 2017 Dec;110:114-120. doi: 10.1016/j.urology.2017.08.043. Epub 2017 Sep 7. Urology. 2017. PMID: 28890151
-
Prospective multicenter study of bone scintigraphy in consecutive patients with newly diagnosed prostate cancer.Clin Nucl Med. 2014 Jan;39(1):26-31. doi: 10.1097/RLU.0000000000000291. Clin Nucl Med. 2014. PMID: 24217537 Clinical Trial.
-
Predictive value of serum prostate specific antigen in detecting bone metastasis in prostate cancer patients using bone scintigraphy.Indian J Nucl Med. 2012 Apr;27(2):81-4. doi: 10.4103/0972-3919.110683. Indian J Nucl Med. 2012. PMID: 23723577 Free PMC article.
-
A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.Eur J Radiol. 2012 May;81(5):1007-15. doi: 10.1016/j.ejrad.2011.01.126. Epub 2011 Feb 26. Eur J Radiol. 2012. PMID: 21354739 Review.
-
Looking for Metastasis in Early Breast Cancer: Does Bone Scan Help? A Retrospective Review.Clin Breast Cancer. 2021 Feb;21(1):e18-e21. doi: 10.1016/j.clbc.2020.07.004. Epub 2020 Jul 8. Clin Breast Cancer. 2021. PMID: 32950408 Review.
Cited by
-
Soluble Programmed Death-Ligand 1 (sPD-L1) as a Promising Marker for Head and Neck Squamous Cell Carcinoma: Correlations With Clinical and Demographic Characteristics.Cureus. 2023 Aug 29;15(8):e44338. doi: 10.7759/cureus.44338. eCollection 2023 Aug. Cureus. 2023. PMID: 37779773 Free PMC article.
References
-
- Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7. New York: Springer; 2010.
-
- Head and Neck Cancers (Version 2.2017). In: NCCN Clinical practice guidelines in Oncology (NCCN Guidelines). National Comprehensive Cancer Network. 2017. https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf. Accessed 12 May 2017.
LinkOut - more resources
Full Text Sources
Other Literature Sources